PI3K signalling: the path to discovery and understanding (original) (raw)

• Sugimoto, Y., Whitman, M., Cantley, L. C. & Erikson, R. L. Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol. Proc. Natl Acad. Sci. USA 81, 2117–2121 (1984).
  CAS PubMed PubMed Central Google Scholar
• Macara, I. G., Marinetti, G. V. & Balduzzi, P. C. Transforming protein of avian sarcoma virus UR2 is associated with phosphatidylinositol kinase activity: possible role in tumorigenesis. Proc. Natl Acad. Sci. USA 81, 2728–2732 (1984).
  CAS PubMed PubMed Central Google Scholar
• Whitman, M., Kaplan, D. R., Schaffhausen, B., Cantley, L. & Roberts, T. M. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 315, 239–242 (1985).
  CAS PubMed Google Scholar
• Kaplan, D. R. et al. Phosphatidylinositol metabolism and polyoma-mediated transformation. Proc. Natl Acad. Sci. USA 83, 3624–3628 (1986).
  CAS PubMed PubMed Central Google Scholar
• Kaplan, D. R. et al. Common elements in growth factor stimulation and oncogenic transformation: 85 KD phosphoprotein and phosphatidylinositol kinase activity. Cell 50, 1021–1029 (1987).
  CAS PubMed Google Scholar
• Whitman, M., Downes, C. P., Keeler, M., Keller, T. & Cantley, L. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 332, 644–646 (1988).
  CAS PubMed Google Scholar
• Traynor-Kaplan, A. E., Harris, A. L., Thompson, B. L., Taylor, P. & Sklar, L. A. An inositol tetrakisphosphate-containing phospholipid in activated neutrophils. Nature 334, 353–356 (1988).
  CAS PubMed Google Scholar
• Auger, K. R., Serunian, L. A., Soltoff, S. P., Libby, P. & Cantley, L. C. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57, 167–175 (1989).
  CAS PubMed Google Scholar
• Traynor-Kaplan, A. E. et al. Transient increase in phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol trisphosphate during activation of human neutrophils. J. Biol. Chem. 264, 15668–15673 (1989).
  CAS PubMed Google Scholar
• Stephens, L., Hawkins, P. T. & Downes, C. P. Metabolic and structural evidence for the existence of a third species of polyphosphoinositide in cells: _D_-phosphatidyl-_myo_-inositol 3-phosphate. Biochem. J. 259, 267–276 (1989).
  CAS PubMed PubMed Central Google Scholar
• Ruderman, N. B., Kapeller, R., White, M. F. & Cantley, L. C. Activation of phosphatidylinositol 3-kinase by insulin. Proc. Natl Acad. Sci. USA 87, 1411–1415 (1990).
  CAS PubMed PubMed Central Google Scholar
• Stephens, L. R., Hughes, K. T. & Irvine, R. F. Pathway of phosphatidylinositol(3,4,5)-trisphosphate synthesis in activated neutrophils. Nature 351, 33–39 (1991).
  CAS PubMed Google Scholar
• Hawkins, P. T., Jackson, T. R. & Stephens, L. R. Platelet-derived growth factor stimulates synthesis of PtdIns(3,4,5)P3 by activating a PtdIns(4,5)P2 3-OH kinase. Nature 358, 157–159 (1992).
  CAS PubMed Google Scholar
• Divecha, N. & Irvine, R. F. Phospholipid signaling. Cell 80, 269–278 (1995).
  CAS PubMed Google Scholar
• Carpenter, C. L. et al. Purification and characterization of phosphoinositide 3-kinase from rat liver. J. Biol. Chem. 265, 19704–19711 (1990).
  CAS PubMed Google Scholar
• Morgan, S. J., Smith, A. D. & Parker, P. J. Purification and characterization of bovine brain type I phosphatidylinositol kinase. Eur. J. Biochem. 191, 761–767 (1990).
  CAS PubMed Google Scholar
• Shibasaki, F., Homma, Y. & Takenawa, T. Two types of phosphatidylinositol 3-kinase from bovine thymus. Monomer and heterodimer form. J. Biol. Chem. 266, 8108–8114 (1991).
  CAS PubMed Google Scholar
• Fry, M. J. et al. Purification and characterization of a phosphatidylinositol 3-kinase complex from bovine brain by using phosphopeptide affinity columns. Biochem. J. 288, 383–393 (1992).
  CAS PubMed PubMed Central Google Scholar
• Courtneidge, S. A. & Heber, A. An 81 kd protein complexed with middle T antigen and pp60c-src: a possible phosphatidylinositol kinase. Cell 50, 1031–1037 (1987).
  CAS PubMed Google Scholar
• Otsu, M. et al. Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase. Cell 65, 91–104 (1991).
  CAS PubMed Google Scholar
• Escobedo, J. A. et al. cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptor. Cell 65, 75–82 (1991).
  CAS PubMed Google Scholar
• Skolnik, E. Y. et al. Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell 65, 83–90 (1991).
  CAS PubMed Google Scholar
• Hiles, I. D. et al. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell 70, 419–429 (1992).
  CAS PubMed Google Scholar
• Backer, J. M. et al. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11, 3469–3479 (1992).
  CAS PubMed PubMed Central Google Scholar
• Herman, P. K. & Emr, S. D. Characterization of Vps34, a gene required for vacuolar protein sorting and vacuole segregation in Saccharomyces cerevisiae. Mol. Cell. Biol. 10, 6742–6754 (1990).
  CAS PubMed PubMed Central Google Scholar
• Schu, P. V. et al. Phosphatidylinositol 3-kinase encoded by yeast _VPS_34 gene essential for protein sorting. Science 260, 88–91 (1993).
  CAS PubMed Google Scholar
• Stephens, L. et al. Characterization of a phosphatidylinositol-specific phosphoinositide 3-kinase from mammalian cells. Curr. Biol. 4, 203–214 (1994).
  CAS PubMed Google Scholar
• Morris, J. Z., Tissenbaum, H. A. & Ruvkun, G. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382, 536–539 (1996).
  CAS PubMed Google Scholar
• MacDougall, L. K., Domin, J. & Waterfield, M. D. A family of phosphoinositide 3-kinases in Drosophila identifies a new mediator of signal transduction. Curr. Biol. 5, 1404–1415 (1995).
  CAS PubMed Google Scholar
• Zhou, K., Takegawa, K., Emr, S. D. & Firtel, R. A. A phosphatidylinositol (PI) kinase gene family in Dictyostelium discoideum: biological roles of putative mammalian p110 and yeast Vps34p PI 3-kinase homologs during growth and development. Mol. Cell. Biol. 15, 5645–5656 (1995).
  CAS PubMed PubMed Central Google Scholar
• Stoyanov, B. et al. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269, 690–693 (1995).
  CAS PubMed Google Scholar
• Stephens, L. et al. A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein βγ subunits. Cell 77, 83–93 (1994).
  CAS PubMed Google Scholar
• Stephens, L. R. et al. The Gβγ sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell 89, 105–114 (1997).
  CAS PubMed Google Scholar
• Stack, J. H., Herman, P. K., Schu, P. V. & Emr, S. D. A membrane-associated complex containing the Vps15 protein kinase and the Vps34 PI 3-kinase is essential for protein sorting to the yeast lysosome-like vacuole. EMBO J. 12, 2195–2204 (1993).
  CAS PubMed PubMed Central Google Scholar
• Virbasius, J. V., Guilherme, A. & Czech, M. P. Mouse p170 is a novel phosphatidylinositol 3-kinase containing a C2 domain. J. Biol. Chem. 271, 13304–13307 (1996).
  CAS PubMed Google Scholar
• Domin, J. et al. Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin. Biochem. J. 326, 139–147 (1997).
  CAS PubMed PubMed Central Google Scholar
• Arcaro, A. et al. Human phosphoinositide 3-kinase C2β, the role of calcium and the C2 domain in enzyme activity. J. Biol. Chem. 273, 33082–33090 (1998).
  CAS PubMed Google Scholar
• Ono, F. et al. A novel class II phosphoinositide 3-kinase predominantly expressed in the liver and its enhanced expression during liver regeneration. J. Biol. Chem. 273, 7731–7736 (1998).
  CAS PubMed Google Scholar
• Misawa, H. et al. Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain. Biochem. Biophys. Res. Commun. 244, 531–539 (1998).
  CAS PubMed Google Scholar
• Maffucci, T., Brancaccio, A., Piccolo, E., Stein, R. C. & Falasca, M. Insulin induces phosphatidylinositol- 3-phosphate formation through TC10 activation. EMBO J. 22, 4178–4189 (2003).
  CAS PubMed PubMed Central Google Scholar
• Zvelebil, M. J. et al. Structural and functional diversity of phosphoinositide 3-kinases. Philos. Trans. R. Soc. Lond. B 351, 217–223 (1996).
  CAS Google Scholar
• Vanhaesebroeck, B., Leevers, S. J., Panayotou, G. & Waterfield, M. D. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci. 22, 267–272 (1997).
  CAS PubMed Google Scholar
• Sjolander, A., Yamamoto, K., Huber, B. E. & Lapetina, E. G. Association of p21ras with phosphatidylinositol 3-kinase. Proc. Natl Acad. Sci. USA 88, 7908–7912 (1991).
  CAS PubMed PubMed Central Google Scholar
• Rodriguez-Viciana, P. et al. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370, 527–532 (1994).
  CAS PubMed Google Scholar
• Kodaki, T. et al. The activation of phosphatidylinositol 3-kinase by Ras. Curr. Biol. 4, 798–806 (1994).
  CAS PubMed Google Scholar
• Wiesinger, D., Gubler, H. U., Haefliger, W. & Hauser, D. Antiinflammatory activity of the new mould metabolite 11-desacetoxy-wortmannin and of some of its derivatives. Experientia 30, 135–136 (1974).
  CAS PubMed Google Scholar
• Arcaro, A. & Wymann, M. P. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296, 297–301 (1993).
  CAS PubMed PubMed Central Google Scholar
• Yano, H. et al. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268, 25846–25856 (1993).
  CAS PubMed Google Scholar
• Okada, T., Sakuma, L., Fukui, Y., Hazeki, O. & Ui, M. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269, 3563–3567 (1994).
  CAS PubMed Google Scholar
• Powis, G. et al. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 54, 2419–2423 (1994).
  CAS PubMed Google Scholar
• Thelen, M., Wymann, M. P. & Langen, H. Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes. Proc. Natl Acad. Sci. USA 91, 4960–4964 (1994).
  CAS PubMed PubMed Central Google Scholar
• Vlahos, C. J., Matter, W. F., Hui, K. Y. & Brown, R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241–5248 (1994).
  CAS PubMed Google Scholar
• Kotani, K. et al. Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling. EMBO J. 13, 2313–2321 (1994).
  CAS PubMed PubMed Central Google Scholar
• Roche, S., Koegl, M. & Courtneidge, S. A. The phosphatidylinositol 3-kinase α is required for DNA synthesis induced by some, but not all, growth factors. Proc. Natl Acad. Sci. USA 91, 9185–9189 (1994).
  CAS PubMed PubMed Central Google Scholar
• Kazlauskas, A. & Cooper, J. A. Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell 58, 1121–1133 (1989).
  CAS PubMed Google Scholar
• Fantl, W. J. et al. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69, 413–423 (1992).
  CAS PubMed Google Scholar
• Coughlin, S. R., Escobedo, J. A. & Williams, L. T. Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science 243, 1191–1194 (1989).
  CAS PubMed Google Scholar
• Hara, K. et al. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc. Natl Acad. Sci. USA 91, 7415–7419 (1994).
  CAS PubMed PubMed Central Google Scholar
• Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O. & Ui, M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J. Biol. Chem. 269, 3568–3573 (1994).
  CAS PubMed Google Scholar
• Wennstrom, S. et al. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr. Biol. 4, 385–393 (1994).
  CAS PubMed Google Scholar
• Wennstrom, S. et al. Membrane ruffling and chemotaxis transduced by the PDGF β-receptor require the binding site for phosphatidylinositol 3′ kinase. Oncogene 9, 651–660 (1994).
  CAS PubMed Google Scholar
• Wymann, M. & Arcaro, A. Platelet-derived growth factor-induced phosphatidylinositol 3-kinase activation mediates actin rearrangements in fibroblasts. Biochem. J. 298, 517–520 (1994).
  CAS PubMed PubMed Central Google Scholar
• Haslam, R. J., Koide, H. B. & Hemmings, B. A. Pleckstrin domain homology. Nature 363, 309–310 (1993).
  CAS PubMed Google Scholar
• Mayer, B. J., Ren, R., Clark, K. L. & Baltimore, D. A putative modular domain present in diverse signaling proteins. Cell 73, 629–630 (1993).
  CAS PubMed Google Scholar
• Harlan, J. E., Hajduk, P. J., Yoon, H. S. & Fesik, S. W. Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature 371, 168–170 (1994).
  CAS PubMed Google Scholar
• Burgering, B. M. & Coffer, P. J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376, 599–602 (1995).
  CAS PubMed Google Scholar
• Franke, T. F. et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81, 727–736 (1995).
  CAS PubMed Google Scholar
• Alessi, D. R. et al. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol. 7, 776–789 (1997).
  CAS PubMed Google Scholar
• Stephens, L. et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279, 710–714 (1998).
  CAS PubMed Google Scholar
• Alessi, D. R. et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr. Biol. 7, 261–269 (1997).
  CAS PubMed Google Scholar
• Stokoe, D. et al. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277, 567–570 (1997).
  CAS PubMed Google Scholar
• Alessi, D. R. et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541–6551 (1996).
  CAS PubMed PubMed Central Google Scholar
• Sarbassov, D. D., Guertin, D. A., Ali, S. M. & Sabatini, D. M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098–1101 (2005).
  CAS PubMed Google Scholar
• Alessi, D. R., Caudwell, F. B., Andjelkovic, M., Hemmings, B. A. & Cohen, P. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 399, 333–338 (1996).
  CAS PubMed Google Scholar
• Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. & Hemmings, B. A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785–789 (1995).
  CAS PubMed Google Scholar
• Datta, S. R. et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231–241 (1997).
  CAS PubMed Google Scholar
• del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R. & Nunez, G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687–689 (1997).
  CAS PubMed Google Scholar
• Zhou, B. P. et al. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/_neu_-overexpressing cells. Nature Cell Biol. 3, 245–52 (2001).
  CAS PubMed Google Scholar
• Viglietto, G. et al. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nature Med. 8, 1136–1144 (2002).
  CAS PubMed Google Scholar
• Shin, I. et al. PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization. Nature Med. 8, 1145–1152 (2002).
  CAS PubMed Google Scholar
• Liang, J. et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nature Med. 8, 1153–1160 (2002).
  CAS PubMed Google Scholar
• Kane, S. et al. A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J. Biol. Chem. 277, 22115–22118 (2002).
  CAS PubMed Google Scholar
• Bruss, M. D., Arias, E. B., Lienhard, G. E. & Cartee, G. D. Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes 54, 41–50 (2005).
  CAS PubMed Google Scholar
• Ogg, S. et al. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389, 994–999 (1997).
  CAS PubMed Google Scholar
• Paradis, S. & Ruvkun, G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 12, 2488–2498 (1998).
  CAS PubMed PubMed Central Google Scholar
• Kops, G. J. et al. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398, 630–634 (1999).
  CAS PubMed Google Scholar
• Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857–868 (1999).
  CAS PubMed Google Scholar
• Biggs, W. H. 3rd, Meisenhelder, J., Hunter, T., Cavenee, W. K. & Arden, K. C. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl Acad. Sci. USA 96, 7421–7426 (1999).
  CAS PubMed PubMed Central Google Scholar
• Guo, S. et al. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J. Biol. Chem. 274, 17184–17192 (1999).
  CAS PubMed Google Scholar
• Rena, G., Guo, S., Cichy, S. C., Unterman, T. G. & Cohen, P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J. Biol. Chem. 274, 17179–17183 (1999).
  CAS PubMed Google Scholar
• Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K. L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nature Cell Biol. 4, 648–657 (2002).
  CAS PubMed Google Scholar
• Potter, C. J., Pedraza, L. G. & Xu, T. Akt regulates growth by directly phosphorylating Tsc2. Nature Cell Biol. 4, 658–665 (2002).
  CAS PubMed Google Scholar
• Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J. & Cantley, L. C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell 10, 151–162 (2002).
  CAS PubMed Google Scholar
• Hawkins, P. T. et al. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr. Biol. 5, 393–403 (1995).
  CAS PubMed Google Scholar
• Cheatham, B. et al. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14, 4902–4911 (1994).
  CAS PubMed PubMed Central Google Scholar
• Chung, J., Grammer, T. C., Lemon, K. P., Kazlauskas, A. & Blenis, J. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370, 71–75 (1994).
  CAS PubMed Google Scholar
• Welsh, G. I., Foulstone, E. J., Young, S. W., Tavare, J. M. & Proud, C. G. Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase. Biochem. J. 303, 15–20 (1994).
  CAS PubMed PubMed Central Google Scholar
• Andjelkovic, M. et al. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 272, 31515–31524 (1997).
  CAS PubMed Google Scholar
• Venkateswarlu, K., Oatey, P. B., Tavare, J. M. & Cullen, P. J. Insulin-dependent translocation of ARNO to the plasma membrane of adipocytes requires phosphatidylinositol 3-kinase. Curr. Biol. 8, 463–466 (1998).
  CAS PubMed Google Scholar
• Li, Z. et al. Phosphatidylinositol 3-kinaseγ activates Bruton's tyrosine kinase in concert with Src family kinases. Proc. Natl Acad. Sci. USA 94, 13820–13825 (1997).
  CAS PubMed PubMed Central Google Scholar
• Isakoff, S. J. et al. Identification and analysis of PH domain-containing targets of phosphatidylinositol 3-kinase using a novel in vivo assay in yeast. EMBO J. 17, 5374–5387 (1998).
  CAS PubMed PubMed Central Google Scholar
• Dowler, S. et al. Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem. J. 351, 19–31 (2000).
  CAS PubMed PubMed Central Google Scholar
• Klarlund, J. K. et al. Signaling by phosphoinositide-3,4,5-trisphosphate through proteins containing pleckstrin and Sec7 homology domains. Science 275, 1927–1930 (1997).
  CAS PubMed Google Scholar
• Welch, H. C. et al. P-Rex1, a PtdIns(3,4,5)P3- and Gβγ-regulated guanine-nucleotide exchange factor for Rac. Cell 108, 809–821 (2002).
  CAS PubMed Google Scholar
• Krugmann, S. et al. Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol. Cell 9, 95–108 (2002).
  CAS PubMed Google Scholar
• Salim, K. et al. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J. 15, 6241–6250 (1996).
  CAS PubMed PubMed Central Google Scholar
• Varnai, P. & Balla, T. Visualization of phosphoinositides that bind pleckstrin homology domains: calcium- and agonist-induced dynamic changes and relationship to myo-[3H]inositol-labeled phosphoinositide pools. J. Cell. Biol. 143, 501–510 (1998).
  CAS PubMed PubMed Central Google Scholar
• Servant, G. et al. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 287, 1037–1040 (2000).
  CAS PubMed PubMed Central Google Scholar
• Meili, R. et al. Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium. EMBO J. 18, 2092–2105 (1999).
  CAS PubMed PubMed Central Google Scholar
• Stenmark, H., Aasland, R., Toh, B. H. & D'Arrigo, A. Endosomal localization of the autoantigen EEA1 is mediated by a zinc-binding FYVE finger. J. Biol. Chem. 271, 24048–24054 (1996).
  CAS PubMed Google Scholar
• Simonsen, A. et al. EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature 394, 494–498 (1998).
  CAS PubMed Google Scholar
• Gaullier, J. M. et al. FYVE fingers bind PtdIns(3)P. Nature 394, 432–433 (1998).
  CAS PubMed Google Scholar
• Patki, V., Lawe, D. C., Corvera, S., Virbasius, J. V. & Chawla, A. A functional PtdIns(3)P-binding motif. Nature 394, 433–434 (1998).
  CAS PubMed Google Scholar
• Burd, C. G. & Emr, S. D. Phosphatidylinositol(3)-phosphate signaling mediated by specific binding to RING FYVE domains. Mol. Cell 2, 157–162 (1998).
  CAS PubMed Google Scholar
• Song, X. et al. Phox homology domains specifically bind phosphatidylinositol phosphates. Biochemistry 40, 8940–8944 (2001).
  CAS PubMed Google Scholar
• Ellson, C. D. et al. PtdIns(3)P regulates the neutrophil oxidase complex by binding to the PX domain of p40phox. Nature Cell Biol. 3, 679–682 (2001).
  CAS PubMed Google Scholar
• Kanai, F. et al. The PX domains of p47phox and p40phox bind to lipid products of PI(3)K. Nature Cell Biol. 3, 675–678 (2001).
  CAS PubMed Google Scholar
• Cheever, M. L. et al. Phox domain interaction with PtdIns(3)P targets the Vam7 t-SNARE to vacuole membranes. Nature Cell Biol. 3, 613–618 (2001).
  CAS PubMed Google Scholar
• Raiborg, C. et al. FYVE and coiled-coil domains determine the specific localisation of Hrs to early endosomes. J. Cell Sci. 114, 2255–2263 (2001).
  CAS PubMed Google Scholar
• Kihara, A., Noda, T., Ishihara, N. & Ohsumi, Y. Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J. Cell Biol. 152, 519–530 (2001).
  CAS PubMed PubMed Central Google Scholar
• Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M. & Bilanges, B. The emerging mechanisms of isoform-specific PI3K signalling. Nature Rev. Mol. Cell. Biol. 11, 329–341 (2010).
  CAS Google Scholar
• Leevers, S. J., Weinkove, D., MacDougall, L. K., Hafen, E. & Waterfield, M. D. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 15, 6584–6594 (1996).
  CAS PubMed PubMed Central Google Scholar
• Chang, H. W. et al. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science 276, 1848–1850 (1997).
  CAS PubMed Google Scholar
• Hirsch, E. et al. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation. Science 287, 1049–1053 (2000).
  CAS PubMed Google Scholar
• Sasaki, T. et al. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science 287, 1040–1046 (2000).
  CAS PubMed Google Scholar
• Li, Z. et al. Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science 287, 1046–1049 (2000).
  CAS PubMed Google Scholar
• Okkenhaug, K. et al. Impaired B and T cell antigen receptor signaling in p110δ PI 3-kinase mutant mice. Science 297, 1031–1034 (2002).
  CAS PubMed Google Scholar
• Clayton, E. et al. A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med. 196, 753–763 (2002).
  CAS PubMed PubMed Central Google Scholar
• Jou, S. T. et al. Essential, nonredundant role for the phosphoinositide 3-kinase p110δ in signaling by the B-cell receptor complex. Mol. Cell. Biol. 22, 8580–8591 (2002).
  CAS PubMed PubMed Central Google Scholar
• Foukas, L. C. et al. Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441, 366–370 (2006).
  CAS PubMed Google Scholar
• Knight, Z. A. et al. A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling. Cell 125, 733–747 (2006).
  CAS PubMed PubMed Central Google Scholar
• Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943–1947 (1997).
  CAS PubMed Google Scholar
• Steck, P. A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet. 15, 356–362 (1997).
  CAS PubMed Google Scholar
• Liaw, D. et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet. 16, 64–67 (1997).
  CAS PubMed Google Scholar
• Marsh, D. J. et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nature Genet. 16, 333–334 (1997).
  CAS PubMed Google Scholar
• Maehama, T. & Dixon, J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375–13378 (1998).
  CAS PubMed Google Scholar
• Samuels, Y. et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554 (2004).
  CAS PubMed Google Scholar
• Campbell, I. G. et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res. 64, 7678–7681 (2004).
  CAS PubMed Google Scholar
• Jimenez, C. et al. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J. 17, 743–753 (1998).
  CAS PubMed PubMed Central Google Scholar
• Philp, A. J. et al. The phosphatidylinositol 3′-kinase p85α gene is an oncogene in human ovarian and colon tumors. Cancer Res. 61, 7426–7429 (2001).
  CAS PubMed Google Scholar
• The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–1068 (2008).
• Jaiswal, B. S. et al. Somatic mutations in p85α promote tumorigenesis through class IA PI3K activation. Cancer Cell 16, 463–474 (2009).
  CAS PubMed PubMed Central Google Scholar
• Blondeau, F. et al. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum. Mol. Genet. 9, 2223–2229 (2000).
  CAS PubMed Google Scholar
• Taylor, G. S., Maehama, T. & Dixon, J. E. Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc. Natl Acad. Sci. USA 97, 8910–8915 (2000).
  CAS PubMed PubMed Central Google Scholar
• Bielas, S. L. et al. Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies. Nature Genet. 41, 1032–1036 (2009).
  CAS PubMed Google Scholar
• Jacoby, M. et al. INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse. Nature Genet. 41, 1027–1031 (2009).
  CAS PubMed Google Scholar
• Sadhu, C., Masinovsky, B., Dick, K., Sowell, C. G. & Staunton, D. E. Essential role of phosphoinositide 3-kinase δ in neutrophil directional movement. J. Immunol. 170, 2647–2654 (2003).
  CAS PubMed Google Scholar
• Camps, M. et al. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nature Med. 11, 936–943 (2005).
  CAS PubMed Google Scholar
• Jackson, S. P. et al. PI 3-kinase p110β: a new target for antithrombotic therapy. Nature Med. 11, 507–514 (2005).
  CAS PubMed Google Scholar
• Walker, E. H., Perisic, O., Ried, C., Stephens, L. & Williams, R. L. Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature 402, 313–320 (1999).
  CAS PubMed Google Scholar
• Huang, C. H. et al. The structure of a human p110α/p85α complex elucidates the effects of oncogenic PI3Kα mutations. Science 318, 1744–1748 (2007).
  CAS PubMed Google Scholar
• Zhang, X. et al. Structure of lipid kinase p110β/p85β elucidates an unusual SH2-domain-mediated inhibitory mechanism. Mol. Cell 41, 567–578.
  CAS PubMed PubMed Central Google Scholar
• Berndt, A. et al. The p110 δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors. Nature Chem. Biol. 6, 117–124.
  CAS PubMed PubMed Central Google Scholar
• Miller, S. et al. Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34. Science 327, 1638–1642 (2010).
  CAS PubMed PubMed Central Google Scholar
• Joly, M., Kazlauskas, A., Fay, F. S. & Corvera, S. Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science 263, 684–687 (1994).
  CAS PubMed Google Scholar
• Volinia, S. et al. A human phosphatidylinositol 3-kinase complex related to the yeast Vps34p–Vps15p protein sorting system. EMBO J. 14, 3339–3348 (1995).
  CAS PubMed PubMed Central Google Scholar
• Yao, R. & Cooper, G. M. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003–2006 (1995).
  CAS PubMed Google Scholar
• Scheid, M. P., Lauener, R. W. & Duronio, V. Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signalling between interleukin-3 and granulocyte-macrophage colony stimulating factor. Biochem. J. 312, 159–162 (1995).
  CAS PubMed PubMed Central Google Scholar
• Vanhaesebroeck, B. et al. P110δ, a novel phosphoinositide 3-kinase in leukocytes. Proc. Natl Acad. Sci. USA 94, 4330–4335 (1997).
  CAS PubMed PubMed Central Google Scholar
• Chantry, D. et al. p110δ, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes. J. Biol. Chem. 272, 19236–19241 (1997).
  CAS PubMed Google Scholar
• Dudek, H. et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661–665 (1997).
  CAS PubMed Google Scholar
• Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H. & Downward, J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16, 2783–2793 (1997).
  CAS PubMed PubMed Central Google Scholar
• Kauffmann-Zeh, A. et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385, 544–548 (1997).
  CAS PubMed Google Scholar
• Kulik, G., Klippel, A. & Weber, M. J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17, 1595–1606 (1997).
  CAS PubMed PubMed Central Google Scholar
• Kennedy, S. G. et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11, 701–713 (1997).
  CAS PubMed Google Scholar
• Ahmed, N. N., Grimes, H. L., Bellacosa, A., Chan, T. O. & Tsichlis, P. N. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl Acad. Sci. USA 94, 3627–3632 (1997).
  CAS PubMed PubMed Central Google Scholar
• Myers, M. P. et al. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl Acad. Sci. USA 95, 13513–13518 (1998).
  CAS PubMed PubMed Central Google Scholar
• Stauffer, T. P., Ahn, S. & Meyer, T. Receptor-induced transient reduction in plasma membrane PtdIns(4,5)P2 concentration monitored in living cells. Curr. Biol. 8, 343–346 (1998).
  CAS PubMed Google Scholar
• Fruman, D. A. et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 283, 393–397 (1999).
  CAS PubMed Google Scholar
• Suzuki, H. et al. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 283, 390–392 (1999).
  CAS PubMed Google Scholar
• Terauchi, Y. et al. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3-kinase. Nature Genet. 21, 230–235 (1999).
  CAS PubMed Google Scholar
• Bi, L., Okabe, I., Bernard, D. J., Wynshaw-Boris, A. & Nussbaum, R. L. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase. J. Biol. Chem. 274, 10963–10968 (1999).
  CAS PubMed Google Scholar
• Gewinner, C. et al. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Cancer Cell 16, 115–125 (2009).
  CAS PubMed PubMed Central Google Scholar
• Fedele, C. G. et al. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers. Proc. Natl Acad. Sci. USA 107, 22231–2236 (2010).
  CAS PubMed PubMed Central Google Scholar